The court said the two companies which have developed the vaccines (Covishield and Covaxin) have more capacity but it seems that it is not being explo
After the Phase 3 data is submitted, India can expect an increase in the current rate of the immunisation programme.
Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, he add